Results 181 to 190 of about 29,210 (297)

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenstrom macroglobulinemia

, 2015
Martin F. M. de Rooij, Annemieke Kuil, Willem Kraan, Marie José Kersten, Steven P. Treon, Steven T. Pals, Marcel Spaargaren   +6 more
openalex   +1 more source

Safety and efficacy of single-agent ibrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): A multicenter, open-label, phase 2 study [PDF]

, 2017
Graham P. Collins, Ariela Noy, Sven de Vos, Catherine Thiéblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Shuo Ma, Morton Coleman, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Ashley M. Smith, Brian Munneke, Isaiah W. Dimery, Darrin M. Beaupre, R. Chen   +16 more
openalex   +1 more source

Combination Treatment of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib and Carfilzomib in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma: Initial Results from a Multicenter Phase 1/2b Study

, 2015
Ajai Chari, Saurabh Chhabra, Saad Z. Usmani, Sarah Larson, Rubén Niesvizky, Jeffrey Matous, Cristina Gasparetto, Beata Holkova, Matthew A. Lunning, Jason Valent, Larry D. Anderson, Chatchada Karanes, Long Kwei, L. Chang, Thorsten Graef, Elizabeth Bilotti, Kevin T. McDonagh   +16 more
openalex   +1 more source

Acquired mutations associated with ibrutinib resistance in Waldenström macroglobulinemia [PDF]

, 2017
Lian Xu, Nicholas Tsakmaklis, Guang Yang, Jiaji G. Chen, Xia Liu, Maria Demos, Amanda Kofides, Christopher J. Patterson, Kirsten Meid, Joshua Gustine, Toni Dubeau, M. Lia Palomba, Ranjana H. Advani, Jorge J. Castillo, Richard R. Furman, Zachary R. Hunter, Steven P. Treon   +16 more
openalex   +1 more source

Zanubrutinib as a salvage therapy for ibrutinib-resistant chronic lymphocytic leukemia: a case report. [PDF]

Front Oncol
Lv Z, Lu P, Jing C, Yi X, Wu X.
europepmc   +1 more source

Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia [PDF]

, 2017
Lotta Hansson, Anna Asklid, Joris Diels, Sandra Eketorp-Sylvan, Johanna Repits, Frans Søltoft, Ulrich Jäger, Anders Österborg   +7 more
openalex   +1 more source

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis. [PDF]

Blood Adv
Guijosa A, Ramirez-Gamero A, Sarosiek S, Branagan AR, von Keudell G, Treon SP, Castillo JJ.   +6 more
europepmc   +1 more source

The Phospholipase Cγ2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein

, 2016
Claudia Walliser, Elisabeth Hermkes, Anja Schade, Sebastian Wiese, Julia Deinzer, Marc Zapatka, Laurent Désiré, Daniel Mertens, Stephan Stilgenbauer, Peter Gierschik   +9 more
openalex   +1 more source

Evaluation of Cardiotoxicity in Lymphoproliferative Patients Treated With Anthracycline and Bruton's Tyrosine Kinase Inhibitor-Based Regimens. [PDF]

Cureus
Bonsu A.
europepmc   +1 more source

Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265 mutations [PDF]

, 2017
Patrizia Mondello, Elliott J. Brea, Elisa de Stanchina, Eneda Toska, Aaron Y. Chang, Myles Fennell, Venkatraman Seshan, Ralph Garippa, David A. Scheinberg, José Baselga, Hans‐Guido Wendel, Anas Younes   +11 more
openalex   +1 more source